Company Filing History:
7 out of 517 
3 out of 444 
1 out of 1 
Years Active: 2001-2019
Title: Alvaro Pascual-Leone: Innovator in Neuromodulation
Introduction
Alvaro Pascual-Leone is a prominent inventor based in Wayland, MA (US), known for his significant contributions to the field of neuromodulation. He holds a total of 10 patents, showcasing his innovative approach to brain stimulation techniques aimed at treating neurological and psychiatric disorders.
Latest Patents
Among his latest patents is a method and system for optimizing the configuration of multisite transcranial current stimulation. This invention includes providing an electric field characteristic target map on the brain's cortex, which consists of multiple cortical targets that are localized and spatially extended. The system calculates optimal currents and locations for electrodes intended to provide transcranial current stimulation, allowing for the simultaneous stimulation of multiple cortical targets with varying types of stimulation. Another notable patent involves techniques for identifying individual target sites for transcranial magnetic stimulation (TMS). This method utilizes functional connectivity magnetic resonance imaging (fMRI) to determine brain regions that are functionally connected, enabling targeted treatment for conditions such as depression.
Career Highlights
Alvaro Pascual-Leone has worked with esteemed organizations such as Beth Israel Deaconess Medical Center and Advanced Neuromodulation Systems. His work has significantly advanced the understanding and application of brain stimulation techniques.
Collaborations
He has collaborated with notable colleagues, including John R. Ives and Michael D. Fox, contributing to the development of innovative solutions in the field of neuromodulation.
Conclusion
Alvaro Pascual-Leone's work exemplifies the intersection of innovation and medical science, making strides in the treatment of neurological disorders through advanced brain stimulation techniques. His contributions continue to influence the field and improve patient outcomes.